Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT-MMO trial

Año publicación: 2025

Subir documento: https://drive.google.com/file/d/1_cbiRWcydFz_osCHqVEXqW8tyvjAWY5N/view?usp=sharing

Nombre investigadores: Carolyn S. P. Lam, Angel Rodriguez, Ali Aminian, Ele Ferrannini, Hiddo J. L. Heerspink, Ania M. Jastreboff, Luke J. Laffin, Ambarish Pandey, Kausik K. Ray, Paul M. Ridker, Arun J. Sanyal, Hannele Yki-Jarvinen, Denise Mason, Michelle Strzelecki, Amy K. Bartee, Can Cui, Karla Hurt, Bruno Linetzky, Mathijs C. Bunck, Steven E. Nissen